ATC codes:
V03AF01
EMLc
Indication
Rhabdomyosarcoma primary site
ICD11 code:
2C25.Z
INN
Mesna
Medicine type
Chemical agent
List type
Complementary
(EML)
(EMLc)
(EMLc)
Additional notes
*injection solution may also be used for oral administration.
Formulations
Parenteral > General injections > IV:
100 mg per mL in 4 mL ampoule ;
100 mg per mL in 10 mL ampoule ;
100 mg per mL in 2 mL ampoule
Oral > Solid > tablet: 400 mg ; 600 mg
Oral > Solid > tablet: 400 mg ; 600 mg
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of a 2 mL vial size of mesna solution for injection to the EML and EMLc.
- the addition of a footnote indicating that the injection solution may also be used for oral administration.